نتایج جستجو برای: vhh antibody

تعداد نتایج: 166690  

2017
Kathryn E. Tiller Ratul Chowdhury Tong Li Seth D. Ludwig Sabyasachi Sen Costas D. Maranas Peter M. Tessier

The identification of mutations that enhance antibody affinity while maintaining high antibody specificity and stability is a time-consuming and laborious process. Here, we report an efficient methodology for systematically and rapidly enhancing the affinity of antibody variable domains while maximizing specificity and stability using novel synthetic antibody libraries. Our approach first uses ...

توسلی, زهرا, روحانی نژاد, حمیده, فلاح مهرآبادی, جلیل,

زمینه و هدف: باکتری استافیلوکوکوس اورئوس با ترشح انتروتوکسین‌های متعدد باعث بیماری‌های مختلف می‌شود، به همین دلیل روش‌های مؤثر و آسان شناسایی انتروتوکسین­ها موردنیاز است. امروزه غالباً از روش‌های ایمونوشیمیایی برمبنای آنتی‌بادی‌های مونوکلونال استفاده می‌شود. در سرم خون خانواده شترسانان آنتی‌بادی‌های زنجیره سنگین یافت شده که VHH یا نانوبادی نامیده می‌شوند. خصوصیات منحصربه‌فرد این آنتی‌بادی‌ها از ...

2014
Min Li Min Zhu Cunzheng Zhang Xianjin Liu Yakun Wan

Nanobodies are the smallest natural fragments with useful properties such as high affinity, distinct paratope and high stability, which make them an ideal tool for detecting target antigens. In this study, we generated and characterized nanobodies against the Cry1Ac toxin and applied them in a biotin-streptavidin based double antibodies (nanobodies) sandwich-ELISA (DAS-ELISA) assay. After immun...

2014
Emmanuel Obishakin Benoit Stijlemans Julien Santi-Rocca Isabel Vandenberghe Bart Devreese Serge Muldermans Philippe Bastin Stefan Magez

Trypanosomes are protozoan parasites that cause diseases in humans and livestock for which no vaccines are available. Disease eradication requires sensitive diagnostic tools and efficient treatment strategies. Immunodiagnostics based on antigen detection are preferable to antibody detection because the latter cannot differentiate between active infection and cure. Classical monoclonal antibodie...

Journal: :Inflammation 2021

The currently used anti-cytokine therapeutic antibodies cannot selectively neutralize pathogenic cytokine signalling that cause collateral damage to protective cascades. single domain chain firstly discovered in Camelidae displays fully functional ability antigen-binding against variable targets, which has been seemed as attractive candidates for the next-generation biologic drug study. In this...

Journal: :Molecular cancer therapeutics 2008
Bernard M Tijink Toon Laeremans Marianne Budde Marijke Stigter-van Walsum Torsten Dreier Hans J de Haard C René Leemans Guus A M S van Dongen

The approximately 15-kDa variable domains of camelid heavy-chain-only antibodies (called Nanobodies) can easily be formatted as multivalent or multispecific single-chain proteins. Because of fast excretion, however, they are less suitable for therapy of cancer. In this study, we aimed for improved tumor targeting of a bivalent anti-epidermal growth factor receptor (EGFR) Nanobody (alphaEGFR-alp...

2011
Chueh-Ling Kuo George A. Oyler Charles B. Shoemaker

Botulinum neurotoxin (BoNT), a Category A biodefense agent, delivers a protease to motor neuron cytosol that cleaves one or more soluble NSF attachment protein receptors (SNARE) proteins involved in neurotransmission to cause a flaccid paralysis. No antidotes exist to reverse symptoms of BoNT intoxication so severely affected patients require artificial respiration with prolonged intensive care...

2017
Peter Bannas Julia Hambach Friedrich Koch-Nolte

Monoclonal antibodies have revolutionized cancer therapy. However, delivery to tumor cells in vivo is hampered by the large size (150 kDa) of conventional antibodies. The minimal target recognition module of a conventional antibody is composed of two non-covalently associated variable domains (VH and VL). The proper orientation of these domains is mediated by their hydrophobic interface and is ...

Journal: :Turkish journal of medical sciences 2017
Shahrbanoo Pourasadi Seyed Latif Mousavi Gargari Masoumeh Rajabibazl Shahram Nazarian

BACKGROUND/AIM Helicobacter pylori is a major health problem. One of the therapeutic approaches is administration of antibody against H. pylori. The methylotrophic Pichia pastoris is a suitable host for expression of recombinant antibody fragments. The aims of this study were the expression and the evaluation of camelid nanobody in the yeast Pichia pastoris. MATERIALS AND METHODS The camelid-...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید